FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs

The Food and Drug Administration (FDA) announced a shame list of companies that try to block generic drugs in order to ramp up profits.

FDA
Source: iStock

Here are the 40 companies that made the FDA’s list:

  • Ranbaxy Laboratories
  • Sun Pharmaceutical Industries Limited
  • Galena Biopharma, Inc.
  • Roche Palo Alto, LLC
  • Bayer AG
  • Novartis AG (ADR) (NYSE:NVS)
  • Mylan NV (NASDAQ:MYL)
  • Acorda Therapeutics Inc (NASDAQ:ACOR)
  • AstraZeneca plc (ADR) (NYSE:AZN)
  • Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE:TEVA)
  • HLS Therapeutics, Inc
  • Orphan Europe SARL
  • King Pharmaceuticals Inc.
  • Cubist Pharmaceuticals
  • Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
  • Cephalon (MM)
  • ApoPharma Inc
  • Shire Plc
  • NPS Pharmaceuticals Inc
  • Boehringer Ingelheim GmbH
  • Questcor Pharmaceuticals Inc
  • Pharmacia & Upjohn Inc
  • Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)
  • Corcept Therapeutics Incorporated (NASDAQ:CORT)
  • BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
  • Gilead Sciences, Inc. (NASDAQ:GILD)
  • Roxane Laboratories, Inc.
  • Danco Laboratories LLC
  • Meda Pharmaceuticals Inc
  • Actelion Ltd.
  • Swedish Orphan Biovitrum AB
  • Celgene Corporation (NASDAQ:CELG)
  • GlaxoSmithKline plc (ADR) (NYSE:GSK)
  • VIVUS, Inc. (NASDAQ:VVUS)
  • Hyperion Therapeutics Inc
  • H. Lundbeck A/S
  • Insys Therapeutics Inc (NASDAQ:INSY)
  • Biogen Inc (NASDAQ:BIIB)
  • Pfizer Inc. (NYSE:PFE)
  • Valeant Pharmaceuticals Intl Inc (NYSE:VRX)

Article printed from InvestorPlace Media, https://investorplace.com/2018/05/fda-generic-drugs/.

©2020 InvestorPlace Media, LLC